Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial-Reference-Cited by-同舟云学术

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Published:2020-10 Issue:10 Volume:20 Page:1193-1203
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Wressnigg Nina,Hochreiter Romana,Zoihsl Oliver,Fritzer Andrea,Bézay Nicole,Klingler Anton,Lingnau Karen,Schneider Martina,Lundberg Urban,Meinke Andreas,Larcher-Senn Julian,Čorbic-Ramljak Irena,Eder-Lingelbach Susanne,Dubischar Katrin,Bender Wolfgang

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference27 articles.

1. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases;Simon;Med Clin North Am,2008

2. Chikungunya as a paradigm for emerging viral diseases: evaluating disease impact and hurdles to vaccine development;Rezza;PLoS Negl Trop Dis,2019

3. Therapeutics and vaccines against chikungunya virus;Ahola;Vector Borne Zoonotic Dis,2015

4. Chikungunya virus and the global spread of a mosquito-borne disease;Weaver;N Engl J Med,2015

5. Chikungunya virus and prospects for a vaccine;Weaver;Expert Rev Vaccines,2012

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenicity and virulence of chikungunya virus;Virulence;2024-09

2. Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents;The Lancet Infectious Diseases;2024-09

3. Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection;Vaccines;2024-08-27

4. Immunogenicity and Safety of Chikungunya Vaccines: A Systematic Review and Meta-Analysis;Vaccines;2024-08-27

5. The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection;Vaccines;2024-08-07